171 related articles for article (PubMed ID: 12819939)
1. Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics.
Yamori T
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S74-9. PubMed ID: 12819939
[TBL] [Abstract][Full Text] [Related]
2. Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel.
Yamori T; Matsunaga A; Sato S; Yamazaki K; Komi A; Ishizu K; Mita I; Edatsugi H; Matsuba Y; Takezawa K; Nakanishi O; Kohno H; Nakajima Y; Komatsu H; Andoh T; Tsuruo T
Cancer Res; 1999 Aug; 59(16):4042-9. PubMed ID: 10463605
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data.
Blower PE; Yang C; Fligner MA; Verducci JS; Yu L; Richman S; Weinstein JN
Pharmacogenomics J; 2002; 2(4):259-71. PubMed ID: 12196914
[TBL] [Abstract][Full Text] [Related]
4. A gene expression database for the molecular pharmacology of cancer.
Scherf U; Ross DT; Waltham M; Smith LH; Lee JK; Tanabe L; Kohn KW; Reinhold WC; Myers TG; Andrews DT; Scudiero DA; Eisen MB; Sausville EA; Pommier Y; Botstein D; Brown PO; Weinstein JN
Nat Genet; 2000 Mar; 24(3):236-44. PubMed ID: 10700175
[TBL] [Abstract][Full Text] [Related]
5. [Chemical evaluation by cancer cell line panel and its role in molecular target-based anticancer drug screening].
Yamori T
Gan To Kagaku Ryoho; 2004 Apr; 31(4):485-90. PubMed ID: 15114687
[TBL] [Abstract][Full Text] [Related]
6. JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
Kong D; Yamori T
Bioorg Med Chem; 2012 Mar; 20(6):1947-51. PubMed ID: 22336246
[TBL] [Abstract][Full Text] [Related]
7. Data mining the NCI cancer cell line compound GI(50) values: identifying quinone subtypes effective against melanoma and leukemia cell classes.
Marx KA; O'Neil P; Hoffman P; Ujwal ML
J Chem Inf Comput Sci; 2003; 43(5):1652-67. PubMed ID: 14502500
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of action mechanisms of toxic chemicals using JFCR39, a panel of human cancer cell lines.
Nakatsu N; Nakamura T; Yamazaki K; Sadahiro S; Makuuchi H; Kanno J; Yamori T
Mol Pharmacol; 2007 Nov; 72(5):1171-80. PubMed ID: 17702889
[TBL] [Abstract][Full Text] [Related]
9. Protodioscin (NSC-698 796): its spectrum of cytotoxicity against sixty human cancer cell lines in an anticancer drug screen panel.
Hu K; Yao X
Planta Med; 2002 Apr; 68(4):297-301. PubMed ID: 11988850
[TBL] [Abstract][Full Text] [Related]
10. Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action.
Huang R; Wallqvist A; Thanki N; Covell DG
Pharmacogenomics J; 2005; 5(6):381-99. PubMed ID: 16103895
[TBL] [Abstract][Full Text] [Related]
11. [A human cell line panel for screening anti-cancer drugs].
Yamori T
Gan To Kagaku Ryoho; 1997 Jan; 24(2):129-35. PubMed ID: 9030223
[TBL] [Abstract][Full Text] [Related]
12. Chemical data mining of the NCI human tumor cell line database.
Wang H; Klinginsmith J; Dong X; Lee AC; Guha R; Wu Y; Crippen GM; Wild DJ
J Chem Inf Model; 2007; 47(6):2063-76. PubMed ID: 17915856
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
14. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
[TBL] [Abstract][Full Text] [Related]
15. Structural revision of sulfated polysaccharide B-1 isolated from a marine Pseudomonas species and its cytotoxic activity against human cancer cell lines.
Matsuda M; Yamori T; Naitoh M; Okutani K
Mar Biotechnol (NY); 2003; 5(1):13-9. PubMed ID: 12925914
[TBL] [Abstract][Full Text] [Related]
16. Web-based tools for mining the NCI databases for anticancer drug discovery.
Fang X; Shao L; Zhang H; Wang S
J Chem Inf Comput Sci; 2004; 44(1):249-57. PubMed ID: 14741034
[TBL] [Abstract][Full Text] [Related]
17. Molecules for the millennium: how will they look? New drug discovery year 2000.
Sausville EA; Johnson JI
Br J Cancer; 2000 Dec; 83(11):1401-4. PubMed ID: 11076644
[TBL] [Abstract][Full Text] [Related]
18. Characterization of kinase suppressor of Ras-1 expression and anticancer drug sensitivity in human cancer cell lines.
Stoeger SM; Cowan KH
Cancer Chemother Pharmacol; 2009 Apr; 63(5):807-18. PubMed ID: 18661133
[TBL] [Abstract][Full Text] [Related]
19. Anticancer metal compounds in NCI's tumor-screening database: putative mode of action.
Huang R; Wallqvist A; Covell DG
Biochem Pharmacol; 2005 Apr; 69(7):1009-39. PubMed ID: 15763539
[TBL] [Abstract][Full Text] [Related]
20. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
